Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply

Aliment Pharmacol Ther. 2014 Mar;39(5):543. doi: 10.1111/apt.12641.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / adverse effects*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Liver Cirrhosis / drug therapy*
  • Male
  • Oligopeptides / adverse effects*
  • Polyethylene Glycols / adverse effects*
  • Ribavirin / adverse effects*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Oligopeptides
  • Polyethylene Glycols
  • Ribavirin